Eli Lilly is escalating its legal push to protect the exclusivity of its high-profile weight-loss and diabetes drugs, ...

Denosumab-bnht is expected to launch in the US in June 2025 per an agreement with the reference product’s manufacturer, Amgen ...

A bill to tax vape products up to 10% – more than tobacco – and ban products not in the FDA approval process will likely see ...

The U.S. Food and Drug Administration recently authorized the marketing of 20 nicotine pouch products under the Zyn brand, including flavors like Wintergreen and the "unflavored" Chill. That ...

Some U.S. health regulators who review medical devices and tobacco products for safety and efficacy are struggling to meet ...

Viagra was approved by the U.S. Food and Drug Administration 27 years ago. Experts say it immediately changed the way we talk ...

A Durham company is pushing back on media reports questioning the safety of its lead product as the firm begins its commercial launch.

Biotechnology firm Humacyte’s (HUMA) shares have declined since the company presented its fourth-quarter and full-year 2024 ...

A Durham biotechnology company has seen its stock price plummet over the past few days amid a stock offering and a media ...

Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...